Malignant salivary gland tumors are rare. The most common tumor site is the parotid.
Aetiologic factors are not clear. Nutrition may be a risk factor, as well as irradiation or a long …

Salivary glands carcinomas are very rare epithelial malignant tumors. In 2013 in Europe,
7800 new diagnoses were estimated, 8.5% of all head and neck cancer. The last WHO …

PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

Background. We analyzed the records of patients with malignant salivary gland tumors, as
diagnosed in centers of the Dutch Head and Neck Oncology Cooperative Group, in search …

PURPOSE: Refined imaging technology, the use of external beam radiation, neutron beam
therapy, and chemotherapy, has altered management strategies for patients with salivary …

Purpose Expression of erbB2 and/or epidermal growth factor receptor (EGFR) is associated
with biologic aggressiveness and poor prognosis in malignant salivary gland tumors …

Objective To analyze the incidence and risk factors for clinically apparent and occult lymph
node metastases in patients with major salivary gland cancers. Design Cohort of patients …

Malignant Salivary Gland Tumors - StatPearls - NCBI Bookshelf US flag An official website of
the United States government Here's how you know NIH NLM Logo Access keys NCBI …

Abstract Objectives/Hypothesis Parotid malignancy may develop as a primary cancer of
salivary tissue or by metastatic involvement of parotid lymph nodes. The aim of the study …

Importance Data on adjuvant concurrent chemoradiotherapy (CRT) after resection of
salivary gland carcinomas (SGCs) are limited. Objective To examine overall survival (OS) …